2020 News

Stay up to date on all that’s happening at Santen USA. For our global headquarters news, visit Santen Worldwide.

News

10.26.2020 Santen Announces U.S. FDA Filing Acceptance of New Drug Application (NDA) for Cyclosporine Topical Ophthalmic Emulsion, 0.1% for the Treatment of Severe Vernal Keratoconjunctivitis in Patiens Ages 4-18

09.17.2020 Santen and U.S. Ophthalmic Company Eyevance Enters into Share Purchase Agreement

07.07.2020 Santen Announces U.S. FDA Acceptance of Premarket Approval (PMA) Application for DE-128 (Microshunt) for Review

06.18.2020 Santen and Orbis Join Forces to Expand Access to Training for Eye Care Professionals

05.08.2020 Santen Reports Consolidated Results for Fiscal 2019

04.01.2020 Santen Inc. Announces Appointment of Tatsuya Kaihara as Corporate Officer and Head of North America Business of Santen Pharmaceutical

03.10.2020 Santen and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular Degeneration

03.05.2020 Santen to Conduct Activities to Raise Awareness on Importance of Early Detection and Treatment of Glaucoma during World Glaucoma Week (March 8-14, 2020)

02.04.2020 Santen Reports 3rd Quarter Fiscal 2019 Consolidated Performance

02.04.2020 Santen and Verily Establish Joint Venture to Develop and Commercialize Unique Ophthalmic Devices

Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved